Since PPARGC1α is a major modulator of mitochondrial biogenesis and NAFLD is associated with changes in PPARGC1α expression, mitochondrial function and copy number [39,40,41]. Here, PPARGC1A is linked to metabolic dysfunction-associated steatotic liver disease.